Letter to the Editor: Aspirin and GLP-1RAs—The missing confounders of empagliflozin for MASLD without diabetes mellitus?

Authors: Yue Hu, Zheng Li, Zhiping Li, Yaqin Zhao, Qing Liu, Qingfang Li, Xinran Cheng

Published: 2024-07-23

DOI: 10.1097/hep.0000000000001033

Source: Full article


Abstract

No abstract found.